Amylyx Pharmaceuticals Inc (AMLX) Stock Price, Quote & News

Company Profile

Amylyx Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States. Its lead products candidate includes avexitide, an investigational, first-in-class glucagon-like peptide-1, or GLP-1 receptor antagonist, which is in phase 3 clinical trial to treat post-bariatric hypoglycemia and congenital hyperinsulinism. The company also develops AMX0035, an oral, fix...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 617 682 0917

Website: amylyx.com

Address:

43 Thorndike Street, Cambridge, United States

SilentBull69 Jan. 15 at 12:34 AM

$AMLX We are looking at multiple catalyst here ..a potential buyout …not to mention three products all separate from each other moving forward We could see $100 a share a year from now

1 · Reply

SocioCobb Jan. 14 at 9:50 PM

$AMLX It matters who you follow, my brothers-

1 · Reply

ajmore Jan. 14 at 6:01 PM

$AMLX Novo Nordisk says on the hunt for deals. They are looking for offering, large and small, that will be complementary to their current offerings. Its the deals making conference and we are there.

1 · Reply

Doughgirl Jan. 14 at 5:44 PM

$AMLX something popping at #JPM26? Love the increase.

0 · Reply

LoveRetailFroth Jan. 14 at 3:04 PM

$AMLX Remember $40 stock here. 3X ☕️

0 · Reply

LoveRetailFroth Jan. 14 at 2:57 PM

$RXRX Good Morning Folks☕️ $TEM $AMLX $SANA LT 💎 s

0 · Reply

LoveRetailFroth Jan. 13 at 2:26 PM

$RXRX Good Morning Folks☕️ $TEM $AMLX $SANA LT 💎 s

0 · Reply

LoveRetailFroth Jan. 12 at 4:51 PM

$RXRX Good Morning Good Long Folks☕️ $TEM $TEMT $DGXX $AMLX

0 · Reply

ajmore Jan. 12 at 2:26 PM

$AMLX presenting at JPM major healthcare conf today.

0 · Reply

LoveRetailFroth Jan. 8 at 2:58 PM

$RXRX Good Morning ☕️😂🤦‍♂️ $AMLX $SANA $TEM $ARBE

0 · Reply

Amylyx Pharmaceuticals Announces Nomination of AMX0318 as a Novel, Long-Acting GLP-1 Receptor Antagonist Development Candidate, Identified in Collaboration with Gubra A/S

Dec 5, 2025, 9:00 AM EST - 5 weeks ago

Amylyx Pharmaceuticals Announces New Safety and Tolerability Cohort 1 Data of AMX0114 in ALS from First-in-Human LUMINA Trial

Dec 3, 2025, 7:53 PM EST - 6 weeks ago

Amylyx Pharmaceuticals, Inc. (AMLX) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Nov 28, 2025, 6:40 PM EST - 6 weeks ago

HALPER SADEH LLC ENCOURAGES AMYLYX PHARMACEUTICALS, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Nov 13, 2025, 2:40 PM EST - 2 months ago

Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Amylyx Pharmaceuticals, Inc. – AMLX

Nov 6, 2025, 2:06 PM EST - 2 months ago

Amylyx Pharmaceuticals, Inc. (AMLX) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 7:00 AM EST - 2 months ago

Amylyx Pharmaceuticals Reports Third Quarter 2025 Financial Results

Nov 3, 2025, 9:00 AM EST - 2 months ago

Amylyx Pharmaceuticals to Present at Upcoming Investor Conferences

Oct 30, 2025, 9:00 AM EDT - 2 months ago

Amylyx Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 6, 2025

Oct 27, 2025, 12:20 PM EDT - 2 months ago

Halper Sadeh LLC Encourages Amylyx Pharmaceuticals, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Oct 16, 2025, 4:40 PM EDT - 3 months ago

AMYLYX INVESTIGATION: Bragar Eagel & Squire, P.C. Urges Amylyx Investors to Contact the Firm Regarding Ongoing Investigation into Amylyx Pharmaceuticals, Inc. on Behalf of Long-Term Stockholders

Sep 10, 2025, 12:06 AM EDT - 4 months ago

Amylyx Pharmaceuticals Announces Pricing of $175 Million Underwritten Public Offering of Common Stock

Sep 9, 2025, 4:01 PM EDT - 4 months ago

Amylyx Pharmaceuticals Announces Proposed Public Offering of Common Stock

Sep 8, 2025, 9:01 PM EDT - 4 months ago

Amylyx Pharmaceuticals, Inc. (AMLX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 2, 2025, 6:14 PM EDT - 4 months ago

Amylyx Pharmaceuticals, Inc. (AMLX) Presents At Citi's Biopharma Back To School Conference Transcript

Aug 27, 2025, 7:28 AM EDT - 5 months ago

Amylyx to stop development of rare brain disorder drug after trial failure

Aug 27, 2025, 7:00 AM EDT - 5 months ago

Amylyx Pharmaceuticals to Discontinue ORION Program of AMX0035 for Progressive Supranuclear Palsy (PSP)

Aug 26, 2025, 9:00 AM EDT - 5 months ago

Amylyx Pharmaceuticals to Participate in Upcoming Investor Conferences

Aug 7, 2025, 10:35 PM EDT - 5 months ago

Amylyx Pharmaceuticals, Inc. (AMLX) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 7:00 AM EDT - 5 months ago

Amylyx Pharmaceuticals Reports Second Quarter 2025 Financial Results

Jul 31, 2025, 9:00 AM EDT - 5 months ago

Amylyx Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 7, 2025

Jul 21, 2025, 4:26 PM EDT - 6 months ago

Amylyx Pharmaceuticals: A High-Risk Pipeline With Strong Upside Potential

Jul 14, 2025, 2:15 PM EDT - 6 months ago

Amylyx Drug Slashes Sugar Spikes Post-Weight Loss Surgery

Jul 13, 2025, 5:00 PM EDT - 6 months ago

Amylyx Pharmaceuticals Presents New Exploratory Analyses from Phase 2 and Phase 2b Clinical Trials of Avexitide in Post-Bariatric Hypoglycemia at ENDO 2025

Jul 8, 2025, 7:00 AM EDT - 6 months ago

Amylyx Pharmaceuticals to Host Event to Discuss Post-bariatric Hypoglycemia and Avexitide at ENDO 2025

Jun 24, 2025, 2:59 PM EDT - 7 months ago

Amylyx Eyes $2B Opportunity In Post-Surgery Sugar Crash Market

Jun 17, 2025, 10:00 AM EDT - 7 months ago

Amylyx Pharmaceuticals, Inc. (AMLX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Jun 15, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Amylyx Pharmaceuticals, Inc. (AMLX) and Encourages Stockholders to Learn More About the Investigation

Jun 12, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Amylyx Pharmaceuticals, Inc. (AMLX) Investors to Inquire about Securities Investigation

Jun 10, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Amylyx Pharmaceuticals, Inc. (AMLX) And Encourages Investors to Reach Out

Jun 8, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Amylyx Pharmaceuticals, Inc. (AMLX) and Encourages Shareholders to Learn More About the Investigation

Jun 5, 2025, 10:00 AM EDT - 7 months ago

Amylyx Pharmaceuticals, Inc. (AMLX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Jun 3, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Amylyx Pharmaceuticals, Inc. (AMLX) Shareholders to Inquire about Securities Investigation

Jun 3, 2025, 7:00 AM EDT - 8 months ago

Amylyx Pharmaceuticals Receives U.S. FDA Fast Track Designation for AMX0114 for the Treatment of Amyotrophic Lateral Sclerosis

Jun 1, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Amylyx Pharmaceuticals, Inc. (AMLX) And Encourages Shareholders to Connect

May 29, 2025, 10:05 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Amylyx Pharmaceuticals, Inc. (AMLX) And Encourages Investors to Connect

May 27, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Amylyx Pharmaceuticals, Inc. (AMLX) Stockholders to Inquire about Securities Investigation

May 25, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Amylyx Pharmaceuticals, Inc. (AMLX) and Encourages Investors to Learn More About the Investigation

May 22, 2025, 10:00 AM EDT - 8 months ago

Amylyx Pharmaceuticals, Inc. (AMLX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

May 21, 2025, 7:00 AM EDT - 8 months ago

Amylyx Pharmaceuticals to Participate in Upcoming June Investor Conferences

May 12, 2025, 7:00 AM EDT - 8 months ago

Amylyx Pharmaceuticals Announces Positive Long-Term Results from Phase 2 HELIOS Clinical Trial of AMX0035 in People with Wolfram Syndrome

May 11, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Amylyx Pharmaceuticals, Inc. (AMLX) And Encourages Stockholders to Reach Out

May 10, 2025, 11:19 AM EDT - 8 months ago

Amylyx Pharmaceuticals, Inc. (AMLX) Q1 2025 Earnings Call Transcript

May 8, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Amylyx Pharmaceuticals, Inc. (AMLX) And Encourages Stockholders to Connect

May 8, 2025, 7:00 AM EDT - 8 months ago

Amylyx Pharmaceuticals Reports First Quarter 2025 Financial Results

May 7, 2025, 8:00 AM EDT - 9 months ago

Amylyx Pharmaceuticals to Participate in Upcoming May Investor Conferences

May 4, 2025, 10:00 AM EDT - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Amylyx Pharmaceuticals, Inc. (AMLX) And Encourages Shareholders to Reach Out

May 1, 2025, 9:00 AM EDT - 9 months ago

Amylyx Pharmaceuticals to Report First Quarter 2025 Financial Results on May 8, 2025

Apr 30, 2025, 7:00 AM EDT - 9 months ago

Amylyx Pharmaceuticals Announces First Participant Dosed in Pivotal Phase 3 LUCIDITY Trial of Avexitide in Post-Bariatric Hypoglycemia

SilentBull69 Jan. 15 at 12:34 AM

$AMLX We are looking at multiple catalyst here ..a potential buyout …not to mention three products all separate from each other moving forward We could see $100 a share a year from now

1 · Reply

SocioCobb Jan. 14 at 9:50 PM

$AMLX It matters who you follow, my brothers-

1 · Reply

ajmore Jan. 14 at 6:01 PM

$AMLX Novo Nordisk says on the hunt for deals. They are looking for offering, large and small, that will be complementary to their current offerings. Its the deals making conference and we are there.

1 · Reply

Doughgirl Jan. 14 at 5:44 PM

$AMLX something popping at #JPM26? Love the increase.

0 · Reply

LoveRetailFroth Jan. 14 at 3:04 PM

$AMLX Remember $40 stock here. 3X ☕️

0 · Reply

LoveRetailFroth Jan. 14 at 2:57 PM

$RXRX Good Morning Folks☕️ $TEM $AMLX $SANA LT 💎 s

0 · Reply

LoveRetailFroth Jan. 13 at 2:26 PM

$RXRX Good Morning Folks☕️ $TEM $AMLX $SANA LT 💎 s

0 · Reply

LoveRetailFroth Jan. 12 at 4:51 PM

$RXRX Good Morning Good Long Folks☕️ $TEM $TEMT $DGXX $AMLX

0 · Reply

ajmore Jan. 12 at 2:26 PM

$AMLX presenting at JPM major healthcare conf today.

0 · Reply

LoveRetailFroth Jan. 8 at 2:58 PM

$RXRX Good Morning ☕️😂🤦‍♂️ $AMLX $SANA $TEM $ARBE

0 · Reply

JohnTrack Jan. 8 at 12:34 PM

$AMLX corporate presentation updated https://www.rapidticker.com/news/amlx-sec-filing-cfa18e

0 · Reply

ajmore Jan. 8 at 12:26 PM

$AMLX you what today's news mean! yes, avexitide works as amylyx goes for the long-acting glp-1 receptor antagonist for pbh and other rare diseases. "Gubra says amylyx selected AMX0318, a long acting....".

0 · Reply

LoveRetailFroth Jan. 7 at 3:52 PM

$RXRX WRONG! Luck combined with Patience is a strategy ☕️💎 $AMLX $SANA $RARE

0 · Reply

LoveRetailFroth Jan. 7 at 3:14 PM

$RXRX $TEM to 150 $TEMT to $50 $AMLX $SANA 10 baggers if you wait. 🚀☕️💎💎💎💎

0 · Reply

LoveRetailFroth Jan. 7 at 2:20 PM

$RXRX Good Morning my Bio 💎 s . $AMLX SMMT $TEM $TEMT

0 · Reply

ajmore Jan. 6 at 5:24 PM

$AMLX keep your eyes on the ball! wolfram= 8 usd per share avexitide = 32 usd per share amx0114=100 usd per share. insiders buying...and holding tight.

1 · Reply

LoveRetailFroth Jan. 6 at 5:10 PM

$AMLX Who are the morons who sell these @ these prices 😂 AMLX - $40 $RXRX - $25 $TEM - $125 $SANA - $25 🤑🚀💎💎💎💎

0 · Reply

LoveRetailFroth Jan. 5 at 12:22 PM

$RCKT Good Morning ☕️ $RNAC $AMLX $IOVA $SMMT

0 · Reply

ajmore Jan. 2 at 5:13 PM

$AMLX presenting week Monday at JPM conference. Large pharma seeking to acquire new drugs as their patents are expiring, the alikes of pfizer ... Exciting time, indeed shorts are over doing it but as they got caught back in Sept with 5 mln shares and stock squeezed 50%, with current unsustainable short it will squeeze 100%. Target 40.

3 · Reply

LoveRetailFroth Jan. 2 at 3:07 PM

$RXRX Good Morning ☕️ Happy New Year 💎 s! $AMLX $SANA $RARE $SMMT

0 · Reply

SilentBull69 Jan. 1 at 9:18 PM

$AMLX So with 12 financial ratings …nine are a buy …two are a strong buy. With Only one is a sell, with two a hold. So The vast majority are VERY positive while insiders recently scooping up hundreds of thousand of more shares. So Why is StockTwist always listing AMLX as a Barish sentiment ..?? Get it together, StockTwist admin

0 · Reply

garygb Dec. 31 at 6:10 PM

$AMLX Holding

0 · Reply

Market Cap	1.38B
Revenue (ttm)	87.37M
Net Income (ttm)	-301.74M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-345.36%
Debt to Equity Ratio	0.00

Volume	1,796,600
Avg Vol	1,536,694
Day's Range	N/A - N/A
Shares Out	109.82M
Stochastic %K	99%
Beta	-0.31
Analysts	Strong Sell
Price Target	$20.22